Henri A. Termeer - Genzyme
Total Compensation: $14.6 million
Details: Termeer spent part of 2007 convincing investors that, unlike Biogen Idec and MedImmune, Genzyme wasn't a good takeover target. For his efforts, Termeer gained $1.5 million in base salary--a 5 percent increase over 2006--about $2.1 million in bonuses, $10 million in option awards, and $105,773 in other expenses like travel, insurance and 401(k) contributions.
Genzyme News:
Genzyme on buyouts: Thanks but no thanks [1]
Icahn sells Genzyme stock [2]
Links:
[1] http://www.fiercebiotech.com/story/genzyme-buyouts-thanks-no-thanks/2007-12-06
[2] http://www.fiercebiotech.com/story/icahn-sells-genzyme-stock/2008-02-15?utm_medium=nl&utm_source=link
[3] http://www.fiercebiotech.com/special-reports/genentech-ceo-arthur-levinson-ceo-pay-report
[4] http://www.fiercebiotech.com/special-reports/ceo-pay-who-makes-what-big-biotech
[5] http://www.fiercebiotech.com/special-reports/gilead-ceo-john-c-martin-ceo-pay-report